Teva Pharmaceutical Industries Limited (LON:0LER)
London flag London · Delayed Price · Currency is GBP · Price in USD
31.06
+0.57 (1.87%)
At close: Dec 22, 2025

LON:0LER Revenue

Teva Pharmaceutical Industries had revenue of $4.48B USD in the quarter ending September 30, 2025, with 3.42% growth. This brings the company's revenue in the last twelve months to $16.78B, up 0.02% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.78B
Revenue Growth
+0.02%
P/S Ratio
2.13
Revenue / Employee
$470.10K
Employees
35,686
Market Cap
26.62B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 201916.89B-1.38B-7.57%
Dec 31, 201818.27B-3.58B-16.39%
Dec 31, 201721.85B-50.00M-0.23%
Dec 31, 201621.90B2.25B11.45%
Dec 31, 201519.65B-620.00M-3.06%
Dec 31, 201420.27B-42.00M-0.21%
Dec 31, 201320.31B-3.00M-0.01%
Dec 31, 201220.32B2.01B10.95%
Dec 31, 201118.31B2.19B13.59%
Dec 31, 201016.12B2.22B15.99%
Dec 31, 200913.90B2.81B25.39%
Dec 31, 200811.09B1.68B17.83%
Dec 31, 20079.41B1.00B11.89%
Dec 31, 20068.41B3.16B60.15%
Dec 31, 20055.25B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Shell200.18B
BP p.l.c.138.32B
Unilever51.24B
AstraZeneca43.24B
HSBC Holdings43.13B
Rio Tinto Group39.22B
GSK plc32.17B
Barclays26.02B
Revenue Rankings